Contract

Supply agreement SARS-CoV-2 mRNA Vaccine

  • Business Energy and Industrial Strategy

F03: Contract award notice

Notice identifier: 2021/S 000-011244

Procurement identifier (OCID): ocds-h6vhtk-02b35e

Published 20 May 2021, 4:21pm



Section one: Contracting authority

one.1) Name and addresses

Business Energy and Industrial Strategy

1 Victoria Street

London

SW1H0ET

Email

VTFContracts@beis.gov.uk

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)

Main address

https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

General public services


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Supply agreement SARS-CoV-2 mRNA Vaccine

Reference number

4764/12/2020-2

two.1.2) Main CPV code

  • 33651600 - Vaccines

two.1.3) Type of contract

Supplies

two.1.4) Short description

The procurement of the mRNA-1273 vaccine.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £1

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement

The procurement of the mRNA-1273 vaccine.

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No

two.2.14) Additional information

Contract value is being withheld due to commercial sensitivity (Reg 50(6)(b) and (c)). Publication may enable competitors to calculate cost per dose. This will commercially prejudice:

(i) the supplier in its negotiations with other national governments; and

(ii) the contracting authority in negotiations with other vaccine vendors.

It may also impact fair competition between vaccine vendors.


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • Extreme urgency brought about by events unforeseeable for the contracting authority

Explanation:

The award of the contract to Moderna is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to find a viable vaccine to end the Covid-19 pandemic (Regulation 32(2)(c)).

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

Contract No

4764/12/2020-2

Title

Supply Agreement SARS-CoV-2 mRNA Vaccine

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

31 December 2020

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Moderna Switzerland GmbH

Aeschenvorstadt 48,

Basel

4051

Country

Switzerland

NUTS code
  • CH - Switzerland
The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £1

Total value of the contract/lot: £1


Section six. Complementary information

six.3) Additional information

Contract end date is being withheld on grounds that release would be contrary to public interest (Reg 50(6)(a)) and commercial sensitivity (Reg 50(6)(b) and (c)). The date is variable based on production and delivery. Given significant challenges to overcome, the end date may set unrealistic expectation for the public/market.

six.4) Procedures for review

six.4.1) Review body

Department of Business, Energy and Industrial Strategy

1 Victoria Street, Westminister

London

SW1H 0ET

Country

United Kingdom